Related Experiment Video
Updated: Aug 30, 2026

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
Published on: March 2, 2016
The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies
Mar Perez1, Rebecca C Craven, Juan C de la Torre
1Department of Neuropharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
By using a reverse genetics system that is based on the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV), we have identified the arenavirus small RING finger Z protein as the main driving force of virus budding. Both LCMV and Lassa fever virus (LFV) Z proteins exhibited self-budding activity, and both substituted efficiently for the late domain that is present in the Gag protein of Rous sarcoma virus. LCMV and LFV Z proteins contain proline-rich motifs that are characteristic of late domains. Mutations in the PPPY motif of LCMV Z severely impaired the formation of virus-like particles. LFV Z contains two different proline-rich motifs, PPPY and PTAP, which are separated by eight amino acids. Mutational analysis revealed that both motifs are required for efficient LFV Z-mediated budding. Both LCMV and LFV Z proteins recruited to the plasma membrane Tsg101, which is a component of the class E vacuolar protein sorting machinery that has been implicated in budding of HIV and Ebola virus. Targeting of Tsg101 by RNA interference caused a strong reduction in Z-mediated budding. These results indicate that Z is the arenavirus functional counterpart of the matrix proteins found in other negative strand enveloped RNA viruses. Moreover, members of the vacuolar protein sorting pathway appear to play an important role in arena-virus budding. These findings open possibilities for antiviral strategies to combat LFV and other hemorrhagic fever arenaviruses.
Insights
The arenavirus Z protein drives virus budding, acting similarly to matrix proteins in other viruses. This discovery offers new avenues for antiviral strategies against hemorrhagic fever arenaviruses.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Arenaviruses, including Lymphocytic choriomeningitis virus (LCMV) and Lassa fever virus (LFV), are significant human pathogens.
- Virus budding, a critical step in viral replication, is essential for the release of new virions.
- The mechanisms governing arenavirus budding have not been fully elucidated.
Purpose of the Study:
- To identify the key viral factor responsible for arenavirus budding.
- To investigate the role of the small RING finger Z protein in the budding process.
- To explore potential antiviral targets within the arenavirus budding pathway.
Main Methods:
- Utilized a reverse genetics system based on Lymphocytic choriomeningitis virus (LCMV).
- Employed mutational analysis of proline-rich motifs (PPPY, PTAP) within the Z protein.
- Investigated the interaction of Z proteins with Tsg101, a component of the vacuolar protein sorting machinery.
- Applied RNA interference to target Tsg101 expression.
Main Results:
- Identified the arenavirus small RING finger Z protein as the primary driver of virus budding.
- Demonstrated that both LCMV and LFV Z proteins exhibit self-budding activity and can substitute for retroviral late domains.
- Showed that proline-rich motifs (PPPY, PTAP) in Z proteins are crucial for efficient budding.
- Confirmed that Z proteins recruit Tsg101 to the plasma membrane, a process essential for budding.
- Observed a significant reduction in budding upon Tsg101 targeting via RNA interference.
Conclusions:
- The arenavirus Z protein functions as the essential counterpart to matrix proteins in other enveloped RNA viruses.
- The vacuolar protein sorting pathway, particularly Tsg101, plays a critical role in arenavirus budding.
- These findings provide a foundation for developing novel antiviral strategies against Lassa fever virus and other hemorrhagic fever arenaviruses.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Human Virome

